相似文献
1
AmpC and OprD are not involved in the mechanism of imipenem hypersusceptibility among Pseudomonas aeruginosa isolates overexpressing the mexCD-oprJ efflux pump.
Antimicrob Agents Chemother. 2005 Nov;49(11):4763-6. doi: 10.1128/AAC.49.11.4763-4766.2005.
2
Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
J Antimicrob Chemother. 2009 Aug;64(2):294-300. doi: 10.1093/jac/dkp185. Epub 2009 May 25.
3
Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
APMIS. 2005 Mar;113(3):187-96. doi: 10.1111/j.1600-0463.2005.apm1130306.x.
4
OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
Int J Antimicrob Agents. 2012 Aug;40(2):168-72. doi: 10.1016/j.ijantimicag.2012.04.004. Epub 2012 May 26.
5
Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates.
Southeast Asian J Trop Med Public Health. 2010 May;41(3):614-24.
6
Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem.
Int J Antimicrob Agents. 2008 May;31(5):427-33. doi: 10.1016/j.ijantimicag.2007.12.016. Epub 2008 Mar 28.
7
[Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms].
Rev Panam Salud Publica. 2011 Dec;30(6):545-8. doi: 10.1590/s1020-49892011001200008.
8
Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa.
J Bacteriol. 2005 Feb;187(4):1384-91. doi: 10.1128/JB.187.4.1384-1391.2005.
9
Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs.
J Antimicrob Chemother. 2006 May;57(5):999-1003. doi: 10.1093/jac/dkl063. Epub 2006 Mar 2.
10
ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
Int J Antimicrob Agents. 2013 Sep;42(3):268-71. doi: 10.1016/j.ijantimicag.2013.06.001. Epub 2013 Jul 20.
引用本文的文献
1
In vivo divergent evolution of cross-resistance to new β-lactam/β-lactamase inhibitor combinations in Pseudomonas aeruginosa following ceftazidime/avibactam treatment.
Infection. 2025 Apr;53(2):635-647. doi: 10.1007/s15010-024-02432-5. Epub 2024 Nov 8.
2
A folate inhibitor exploits metabolic differences in Pseudomonas aeruginosa for narrow-spectrum targeting.
Nat Microbiol. 2024 May;9(5):1207-1219. doi: 10.1038/s41564-024-01665-2. Epub 2024 Apr 9.
3
Intrinsic Antibacterial Activity of Xeruborbactam : Assessing Spectrum and Mode of Action.
Antimicrob Agents Chemother. 2022 Oct 18;66(10):e0087922. doi: 10.1128/aac.00879-22. Epub 2022 Sep 14.
4
The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.
Clin Microbiol Rev. 2015 Apr;28(2):337-418. doi: 10.1128/CMR.00117-14.
5
Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth.
Antimicrob Agents Chemother. 2011 Oct;55(10):4560-8. doi: 10.1128/AAC.00519-11. Epub 2011 Aug 1.
6
Genetic determinants involved in the susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics.
Antimicrob Agents Chemother. 2010 Oct;54(10):4159-67. doi: 10.1128/AAC.00257-10. Epub 2010 Aug 2.
7
The relative contribution of efflux and target gene mutations to fluoroquinolone resistance in recent clinical isolates of Pseudomonas aeruginosa.
Eur J Clin Microbiol Infect Dis. 2010 Mar;29(3):279-88. doi: 10.1007/s10096-009-0852-z. Epub 2010 Jan 23.
8
Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.
Clin Microbiol Rev. 2009 Oct;22(4):582-610. doi: 10.1128/CMR.00040-09.
9
Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican Medical Center Hospitals: dissemination of KPC and IMP-18 beta-lactamases.
Antimicrob Agents Chemother. 2009 Apr;53(4):1660-4. doi: 10.1128/AAC.01172-08. Epub 2009 Feb 2.
10
Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4.
Antimicrob Agents Chemother. 2009 Feb;53(2):557-62. doi: 10.1128/AAC.00734-08. Epub 2008 Nov 17.
本文引用的文献
1
Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.
Diagn Microbiol Infect Dis. 2004 Sep;50(1):43-50. doi: 10.1016/j.diagmicrobio.2004.05.004.
2
Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance.
FEMS Microbiol Lett. 2004 Jul 1;236(1):137-43. doi: 10.1016/j.femsle.2004.05.039.
3
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
Methods. 2001 Dec;25(4):402-8. doi: 10.1006/meth.2001.1262.
4
Hypersusceptibility of the Pseudomonas aeruginosa nfxB mutant to beta-lactams due to reduced expression of the ampC beta-lactamase.
Antimicrob Agents Chemother. 2001 Apr;45(4):1284-6. doi: 10.1128/AAC.45.4.1284-1286.2001.
5
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.
Nature. 2000 Aug 31;406(6799):959-64. doi: 10.1038/35023079.
6
Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa.
J Bacteriol. 1999 Oct;181(20):6300-5. doi: 10.1128/JB.181.20.6300-6305.1999.
7
Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids.
Antimicrob Agents Chemother. 1999 May;43(5):1085-90. doi: 10.1128/AAC.43.5.1085.
8
Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems.
Antimicrob Agents Chemother. 1999 Feb;43(2):424-7. doi: 10.1128/AAC.43.2.424.
9
Characterization of the MexC-MexD-OprJ multidrug efflux system in DeltamexA-mexB-oprM mutants of Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1998 Aug;42(8):1938-43. doi: 10.1128/AAC.42.8.1938.
10
Susceptibility to beta-lactam antibiotics of Pseudomonas aeruginosa overproducing penicillin-binding protein 3.
Antimicrob Agents Chemother. 1997 May;41(5):1158-61. doi: 10.1128/AAC.41.5.1158.
Zotero 插件